Stay updated with breaking news from ப்ரொஃப் சாஹின். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The experts behind the BioNTech coronavirus jab have developed another vaccine which they claim cures multiple sclerosis (MS) in mice. The new MS vaccine works in a similar way to the coronavirus vaccine, manufactured in conjunction with US pharmaceutical giant Pfizer. A piece of genetic material known as mRNA is inserted into a person s arm and forces the body s own cells to produce a protein that confers immunity. In the case of the coronavirus vaccine, this protein mimics the virus s protruding spike, kickstarting the immune system to start making antibodies. If a person later contracts the coronavirus, the immune system rapidly creates antibodies again and fights the infection before it can take hold or spread. ....
EU didn t order enough vaccine, say German scientists behind Pfizer/BioNTech jab I was amazed says Prof Ugur Sahin as EU faces shortage of vaccine developed in Germany Özlem Türeci and Prof Ugur Sahin of BioNTech, The German couple behind the Pfizer-BioNTech coronavirus vaccine have criticised the European Union for failing to order enough doses. “The process in Europe was not as quick and straightforward as it was in other countries,” Prof Ugur Sahin, the billionaire scientist and CEO of BioNTech, told Spiegel magazine. “There was an assumption that many other companies would come with vaccines. Obviously the thinking which prevailed was: we ll get enough, it won t be so bad, and we have it under control. I was amazed.” ....
Pfizer vaccine inventor Ugur Sahin hails once-in-a-lifetime experience as Dubai starts inoculations thenationalnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenationalnews.com Daily Mail and Mail on Sunday newspapers.
Prof Ugur Sahin That feeling is something that many of us had. You are learning, you are doing science, you are improving technology and then you are prepared to deliver when it is desperately needed. “It feels fantastic, because that is why we started. We want to make a difference and provide benefit to mankind and we feel happy and grateful that we’re in a position to do that. The vaccine is the first based on messenger RNA (mRNA), a type of genetic material, to receive approval for use in people and is 95 per cent effective at preventing Covid-19. ....